Isoxyl

WikiDoc Resources for Isoxyl
Articles
Most recent articles on Isoxyl Most cited articles on Isoxyl Review articles on Isoxyl Articles on Isoxyl in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Isoxyl Images of Isoxyl Photos of Isoxyl Podcasts & MP3s on Isoxyl Videos on Isoxyl
Evidence Based Medicine
Cochrane Collaboration on Isoxyl Bandolier on Isoxyl TRIP on Isoxyl
Clinical Trials
Ongoing Trials on Isoxyl at Clinical Trials.gov Trial results on Isoxyl Clinical Trials on Isoxyl at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Isoxyl NICE Guidance on Isoxyl NHS PRODIGY Guidance FDA on Isoxyl CDC on Isoxyl
Books
Books on Isoxyl
News
Isoxyl in the news Be alerted to news on Isoxyl News trends on Isoxyl
Commentary
Blogs on Isoxyl
Definitions
Definitions of Isoxyl
Patient Resources / Community
Patient resources on Isoxyl Discussion groups on Isoxyl Patient Handouts on Isoxyl Directions to Hospitals Treating Isoxyl Risk calculators and risk factors for Isoxyl
Healthcare Provider Resources
Symptoms of Isoxyl Causes & Risk Factors for Isoxyl Diagnostic studies for Isoxyl Treatment of Isoxyl
Continuing Medical Education (CME)
CME Programs on Isoxyl
International
Isoxyl en Espanol Isoxyl en Francais
Business
Isoxyl in the Marketplace Patents on Isoxyl
Experimental / Informatics
List of terms related to Isoxyl

Isoxyl (Thiocarlide; 4,4'-diisoamyloxydiphenylthiourea) is a thiourea chemical that was used in the 1960s to successfully treat tuberculosis (TB). It has considerable antimycobacterial activity in vitro and is effective against multi-drug resistant strains of Mycobacterium tuberculosis. Isoxyl inhibits M. bovis with six hours of exposure, which is similar to isoniazid and ethionamide, two other prominent anti-TB drugs. Unlike these two drugs, however, isoxyl also partially inhibits the synthesis of fatty acids.

Isoxyl was developed by a Belgian company, Continental Pharma S.A. Belgo-Canadienne in Brussels, Belgium. The head researcher was Professor N. P. Buu-Hoi, head of Continental Pharma's Research Division.